Navitus is committed to providing high quality services to its members and, as part of this commitment, strives to protect member safety. We have created policies and procedures in the event of drug recalls or situations that pose a threat to the health and safety of our members. We monitor these situations closely and follow the guidelines of the U.S. Food and Drug Administration (FDA). Recent drug recalls include:
On October 28, 2015
Sanofi US voluntarily recalled all Auvi-Q® (epinephrine injection, USP). The recall involves all Auvi-Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths for hospitals, retailers and consumers. This includes lot number 2299596 through 3037230 with expiration dates between March 2016 and December 2016. The products potentially have inaccurate dosage delivery. Please see the FDA’s website for information about this recall.
On November 21, 2014
Aurobindo Pharma USA, Inc. voluntarily recalled one lot of 100-count gabapentin capsules, USP 300 mg. Some capsules in this lot may be empty, resulting in missed or low doses. The affected capsules come from lot number GESB14011-A. If you think this recall affects you, please contact the pharmacy that gave you the prescription. Please see the FDA website for more information about this recall.
On August 7, 2014
Cubist Pharmaceuticals voluntarily recalled certain lots of CUBICIN® (daptomycin for injection). These lots may potentially contain glass particulate matter in some of the vials. If glass particulate is present in an intravenous drug this poses a potential safety risk to patients. This can include a life-threatening blood clot. If you have a prescription from one of the affected lots, you should contact Cubist. You can call them at 855-534-8309 between the hours of 9 a.m. to 7 p.m. EDT, Monday through Friday. Please see the FDA’s website for information about this recall.
On June 6, 2014
Diabetic Supply of Suncoast, Inc. voluntarily recalled BMB-BA006A Advocate Redi-Code+ Blood Glucose Test Strips manufactured by BroadMaster Bio-Tech Corp. The package label omitted the correct meter name, BMB-BA006A, for use of the strips. This could lead to use of the strips in the wrong meter, which could produce false glucose results leading to undetected hypoglycemia or hyperglycemia and serious health risks, including death. If you have test strips affected by this recall, you should contact Diabetic Supply of Suncoast, Inc. at 561-296-0488 between the hours of 9:00 am and 5:00 pm Monday through Friday EDT. Please see the FDA’s website about this recall for more information.
On May 8, 2014
Navitus Health Solutions, LLC is a transparent Pharmacy Benefit Manager for a variety of health care plans. Navitus is not owned or operated by an entity related to the pharmaceutical manufacturing industry. Navitus is also not responsible for the manufacture, distribution or recall of any medication. This notification is meant solely to provide information to our clients, members and policyholders, regarding the various recalls of medications by the FDA. Navitus assumes no liability for the information contained in these notifications.
Zydus Pharmaceuticals USA Inc. voluntarily recalled one lot (Lot #: MN9081, Expiry: 09/2015) of promethazine 25 mg tablets. Cadila Healthcare Ltd. manufactures these tablets. The bottles may contain atenolol 25 mg tablets mixed in with the promethazine. Promethazine is a medication used to treat allergies. Atenolol is a medication used to treat high blood pressure and may cause your heart to slow, lower your blood pressure and/or cause dizziness. If you think this recall affects you, please contact the pharmacy that gave you the prescription or your prescriber. If you have a prescription from the affected lot, you should contact Zydus Pharmaceuticals at 1-877-993-8779 (option 2), Monday through Friday from 9 am to 5 pm ET. Please see the FDA’s website about this recall for more information.